Interestingly, anti-TNF-α agents used for IBD treatment can induce paradoxical psoriasis due to the hyperactivation of pDCs and their secretion of IFN-γ (IFN secretion is generally inhibited by TNF-α). The gene discussed is TNF; the disease is psoriasis.